Symptomatic Venous Thromboembolism in Patients with Malignant Bone and Soft Tissue Tumors: A Prospective Multicenter Cohort Study.

Shintaro IwataAkira KawaiTakafumi UedaTakeshi Ishiinull null

Published in: Annals of surgical oncology (2020)

The incidence of sVTE in this series of patients with bone and soft tissue sarcomas was 1.18%, which was relatively lower than in previous retrospective studies. We identified the risk factors for sVTE specific to patients with malignant bone and soft tissue tumors, and these included ischemic heart disease, tumor size, and elevation of the preoperative platelet count.

Keyphrases

soft tissue
venous thromboembolism
cross sectional
bone mineral density
risk factors
patients undergoing
direct oral anticoagulants
high grade
bone loss
case control